Philippe Vincent
Biographic Data
| ID | 7643467 |
|---|---|
| NAME | Philippe Vincent |
| GIVEN NAMES | Philippe |
| FAMILY NAME | Vincent |
| SIGNATURE | VINCENT P |
| AFFILIATIONS | Université de Montréal |
| ORCID | 0000-0001-9194-6755 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Probable Serotonin Syndrome Precipitated by the Addition of Trazodone to Lurasidone and Valproic Acid
Serotonin syndrome (SS) is a serious medical condition characterized by altered mental status, autonomic instability and neuromuscular abnormalities. It is caused by the use of one or multiple serotoninergic medication(s), which results in excessive activation of serotoninergic receptors. Here, we present a case of probable SS following the addition of trazodone to treat insomnia. Besides trazodone, the patient was prescribed valproic acid, luras…
Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy
Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder
Background Cluster B personality disorders (PDs) are considered some of the most severe mental health conditions. Scarce evidence exists about the real-world utilization of psychotropics for cluster B PD individuals. Objective We aimed to uncover trends and patterns of psychotropic medication use among individuals diagnosed with cluster B PD in the year before and after their diagnosis and to identify factors associated with medication use in a l…
No prominent works on this page.
Psychotropic medication use pre and post-diagnosis of cluster B personality disorder
Background Cluster B personality disorders (PDs) are considered some of the most severe mental health conditions. Scarce evidence exists about the real-world utilization of psychotropics for cluster B PD individuals. Objective We aimed to uncover trends and patterns of psychotropic medication use among individuals diagnosed with cluster B PD in the year before and after their diagnosis and to identify factors associated with medication use in a l…
Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy
Psilocybin has reemerged as a promising treatment for difficult-to-treat depression (DTD). Although there is limited evidence regarding interactions between psilocybin and other psychotropic drugs, clinical trials require that patients discontinue their antidepressants before study entry to isolate the benefits of psilocybin and to minimize the risk of adverse events. We present the first case of an adult patient with DTD who received psilocybin-…
Probable Serotonin Syndrome Precipitated by the Addition of Trazodone to Lurasidone and Valproic Acid
Serotonin syndrome (SS) is a serious medical condition characterized by altered mental status, autonomic instability and neuromuscular abnormalities. It is caused by the use of one or multiple serotoninergic medication(s), which results in excessive activation of serotoninergic receptors. Here, we present a case of probable SS following the addition of trazodone to treat insomnia. Besides trazodone, the patient was prescribed valproic acid, luras…
Anxiety (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Mood (2 works) · Psychiatry (2 works) · Serotonergic (2 works) · Serotonin (2 works) · Adverse effect (1 work) · Alternative medicine (1 work) · Antidepressant (1 work)